USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$10.00M
Market Cap
-
P/E Ratio
-21.29
EPS
$17.39
52 Week High
$5.00
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$551K |
Total Revenue | $0 |
Cost Of Revenue | $551K |
Costof Goods And Services Sold | $551K |
Operating Income | -$33M |
Selling General And Administrative | $13M |
Research And Development | $19M |
Operating Expenses | $31M |
Investment Income Net | - |
Net Interest Income | $2.5M |
Interest Income | $2.6M |
Interest Expense | $90K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $551K |
Income Before Tax | -$30M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$30M |
Comprehensive Income Net Of Tax | - |
Ebit | -$30M |
Ebitda | -$30M |
Net Income | -$30M |
Field | Value (USD) |
---|---|
Total Assets | $45M |
Total Current Assets | $42M |
Cash And Cash Equivalents At Carrying Value | $10M |
Cash And Short Term Investments | $10M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $3.4M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $31M |
Other Current Assets | $594K |
Other Non Current Assets | - |
Total Liabilities | $7M |
Total Current Liabilities | $5.4M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.3M |
Total Non Current Liabilities | $1.5M |
Capital Lease Obligations | $3.8M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.8M |
Other Current Liabilities | $1.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $38M |
Treasury Stock | - |
Retained Earnings | -$262M |
Common Stock | $3K |
Common Stock Shares Outstanding | $25M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$25M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.3M |
Capital Expenditures | $146K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $22M |
Cashflow From Financing | -$787K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$30M |
Field | Value (USD) |
---|---|
Gross Profit | -$551K |
Total Revenue | $0 |
Cost Of Revenue | $551K |
Costof Goods And Services Sold | $551K |
Operating Income | -$33M |
Selling General And Administrative | $13M |
Research And Development | $19M |
Operating Expenses | $31M |
Investment Income Net | - |
Net Interest Income | $2.5M |
Interest Income | $2.6M |
Interest Expense | $90K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $551K |
Income Before Tax | -$30M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$30M |
Comprehensive Income Net Of Tax | - |
Ebit | -$30M |
Ebitda | -$30M |
Net Income | -$30M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, is dedicated to the discovery and development of therapies with an initial focus on cancer treatments. The company is headquartered in Rockville, Maryland.